Philip C. Johnson

6.3k total citations · 2 hit papers
109 papers, 4.6k citations indexed

About

Philip C. Johnson is a scholar working on Epidemiology, Infectious Diseases and Physiology. According to data from OpenAlex, Philip C. Johnson has authored 109 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Epidemiology, 21 papers in Infectious Diseases and 20 papers in Physiology. Recurrent topics in Philip C. Johnson's work include Fungal Infections and Studies (18 papers), Antifungal resistance and susceptibility (17 papers) and Spaceflight effects on biology (9 papers). Philip C. Johnson is often cited by papers focused on Fungal Infections and Studies (18 papers), Antifungal resistance and susceptibility (17 papers) and Spaceflight effects on biology (9 papers). Philip C. Johnson collaborates with scholars based in United States, Vietnam and Grenada. Philip C. Johnson's co-authors include George A. Sarosi, Richard J. Hamill, William H. Clements, Daren M. Carlisle, James M. Lazorchak, Jack D. Sobel, John R. Graybill, Dominic Labriola, Nancy Ruíz and Richard Stryker and has published in prestigious journals such as Science, New England Journal of Medicine and JAMA.

In The Last Decade

Philip C. Johnson

103 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

1999 788 citations Schlomo Staszewski, Javier O Morales-Ramirez et al. New England Journal of Medicine profile →
Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome

1997 540 citations Charles M. van der Horst, Michael S. Saag et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Philip C. Johnson United States	29	2.6k	1.9k	681	372	295	109	4.6k
Catherine B. Small United States	26	987 0.4×	1.1k 0.6×	429 0.6×	253 0.7×	442 1.5×	65	3.5k
Susanna Cunningham–Rundles United States	33	910 0.3×	1.4k 0.7×	821 1.2×	408 1.1×	299 1.0×	76	5.7k
Margaret Fitzgerald United Kingdom	39	1.0k 0.4×	1.3k 0.7×	171 0.3×	504 1.4×	471 1.6×	167	5.1k
Ross E. McKinney United States	33	1.3k 0.5×	736 0.4×	874 1.3×	373 1.0×	444 1.5×	121	3.8k
Anna Maria Cattelan Italy	39	1.9k 0.7×	1.1k 0.6×	470 0.7×	441 1.2×	326 1.1×	235	5.8k
Douglas Wilson South Africa	34	1.9k 0.7×	1.6k 0.8×	168 0.2×	673 1.8×	128 0.4×	112	3.9k
Gioacchino Angarano Italy	31	2.3k 0.9×	1.5k 0.8×	1.5k 2.3×	212 0.6×	282 1.0×	227	4.6k
Fred R. Sattler United States	44	2.0k 0.8×	1.9k 1.0×	906 1.3×	415 1.1×	276 0.9×	122	5.4k
Gunther F. Craun United States	35	1.9k 0.7×	815 0.4×	139 0.2×	175 0.5×	378 1.3×	96	5.9k
Michael T. Brady United States	33	1.4k 0.5×	1.5k 0.8×	418 0.6×	538 1.4×	550 1.9×	99	3.8k

Countries citing papers authored by Philip C. Johnson

Since Specialization

Citations

This map shows the geographic impact of Philip C. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip C. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip C. Johnson more than expected).

Fields of papers citing papers by Philip C. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip C. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip C. Johnson. The network helps show where Philip C. Johnson may publish in the future.

Co-authorship network of co-authors of Philip C. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Philip C. Johnson. A scholar is included among the top collaborators of Philip C. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip C. Johnson. Philip C. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Beach, R S, et al.. (2025). Pre-exposure Prophylaxis (PrEP) For Prevention of Human Immunodeficiency Virus: A Primary Practice Approach. Journal of General Internal Medicine. 40(10). 2369–2375.

Johnson, Philip C., et al.. (2014). Yield of Diagnostic Tests and Its Impact on Cost in Adult Patients with Syncope Presenting to a Community Hospital. Southern Medical Journal. 107(11). 707–714. 25 indexed citations

Hage, Chadi A., Timothy E. Stump, Carol A. Kauffman, et al.. (2011). Histoplasma Antigen Clearance during Treatment of Histoplasmosis in Patients with AIDS Determined by a Quantitative Antigen Enzyme Immunoassay. Clinical and Vaccine Immunology. 18(4). 661–666. 49 indexed citations

Hamill, Richard J., Jack D. Sobel, Wafaa El‐Sadr, et al.. (2010). Comparison of 2 Doses of Liposomal Amphotericin B and Conventional Amphotericin B Deoxycholate for Treatment of AIDS‐Associated Acute Cryptococcal Meningitis: A Randomized, Double‐Blind Clinical Trial of Efficacy and Safety. Clinical Infectious Diseases. 51(2). 225–232. 120 indexed citations

Sungkanuparph, Somnuek, S. G. Filler, Ploenchan Chetchotisakd, et al.. (2009). Cryptococcal Immune Reconstitution Inflammatory Syndrome after Antiretroviral Therapy in AIDS Patients with Cryptococcal Meningitis: A Prospective Multicenter Study. Clinical Infectious Diseases. 49(6). 931–934. 75 indexed citations

Wheat, L. Joseph, Gretchen A. Cloud, Philip C. Johnson, et al.. (2001). Clearance of Fungal Burden during Treatment of Disseminated Histoplasmosis with Liposomal Amphotericin B versus Itraconazole. Antimicrobial Agents and Chemotherapy. 45(8). 2354–2357. 63 indexed citations

Hardin, Dana S., et al.. (1999). Increased Leucine Turnover and Insulin Resistance in Men with Advanced HIV Infection. Journal of Investigative Medicine. 47(8). 405–413. 9 indexed citations

Saag, Michael S., Gretchen A. Cloud, John R. Graybill, et al.. (1999). A Comparison of Itraconazole Versus Fluconazole as Maintenance Therapy for AIDS‐Associated Cryptococcal Meningitis. Clinical Infectious Diseases. 28(2). 291–296. 157 indexed citations

Staszewski, Schlomo, Javier O Morales-Ramirez, Karen T. Tashima, et al.. (1999). Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults. New England Journal of Medicine. 341(25). 1865–1873. 788 indexed citations breakdown →

10.

Nehete, Pramod N., Steven J. Schapiro, Philip C. Johnson, et al.. (1998). A Synthetic Peptide from the First Conserved Region in the Envelope Protein gp160 Is a Strong T-Cell Epitope in HIV-Infected Chimpanzees and Humans. Viral Immunology. 11(3). 147–158. 21 indexed citations

11.

Horst, Charles M. van der, Michael S. Saag, Gretchen A. Cloud, et al.. (1997). Treatment of Cryptococcal Meningitis Associated with the Acquired Immunodeficiency Syndrome. New England Journal of Medicine. 337(1). 15–21. 540 indexed citations breakdown →

12.

Michalsen, Andrej, George L. Delclos, Sarah A. Felknor, et al.. (1997). Compliance with Universal Precautions Among Physicians. Journal of Occupational and Environmental Medicine. 39(2). 130–137. 80 indexed citations

13.

Delclos, George L., Sarah A. Felknor, Philip C. Johnson, et al.. (1997). The Effectiveness of a Needleless Intravenous Connection System An Assessment by Injury Rate and User Satisfaction. Infection Control and Hospital Epidemiology. 18(3). 175–182. 27 indexed citations

14.

Gershon, Robyn, David Vlahov, Sarah A. Felknor, et al.. (1995). Compliance with universal precautions among health care workers at three regional hospitals. American Journal of Infection Control. 23(4). 225–236. 249 indexed citations

15.

Sarosi, George A. & Philip C. Johnson. (1992). Disseminated Histoplasmosis in Patients Infected with Human Immunodeficiency Virus. Clinical Infectious Diseases. 14(Supplement_1). S60–S67. 76 indexed citations

16.

Jauchem, James R., James M. Waligora, & Philip C. Johnson. (1990). Blood biochemical and cellular changes during decompression and simulated extravehicular activity. International Archives of Occupational and Environmental Health. 62(5). 391–396. 2 indexed citations

17.

Johnson, Philip C. & Charles D. Ericsson. (1990). Acute diarrhea in developed countries. The American Journal of Medicine. 88(6). S5–S9. 25 indexed citations

18.

Fischer, Duncan K., et al.. (1989). Papillary Carcinoma of the Thyroid: Additional Evidence in Support of a Familial Component. Cancer Investigation. 7(4). 323–325. 21 indexed citations

19.

Johnson, Philip C., et al.. (1966). A VITAMIN, ANABOLIC, STIMULANT MIXTURE. IS THIS FORM OF MEDICATION ADVANTAGEOUS FOR DEBILITATED GERIATRIC PATIENTS?. Journal of the American Geriatrics Society. 14(5). 525–532. 4 indexed citations

20.

Johnson, Philip C. & Y. F. Masters. (1962). Effect of sustained release on absorption and excretion of S35-labeled trimeprazine tartrate.. PubMed. 59. 993–9. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact